TheracosBio
PrivateLast Round
Debt
Aug 22, 2023
Company Overview
TheracosBio operates in Healthcare & Life Sciences and is based in Marlborough, Massachusetts. Its latest recorded funding round was a Debt round in August 2023.
TheracosBio is a biopharmaceutical company that develops and commercializes affordable therapeutic agents for prevalent diseases, with a primary focus on type 2 diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TheracosBio Comparables
Compare TheracosBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Johnson & Johnson | 77% | |
| Boehringer Ingelheim | 77% | |
| Eli Lilly and Company | 76% |
For institutional investors. Book with your work email.
TheracosBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Aug 22, 2023 | ||||
| VC Round | Jan 15, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
TheracosBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HealthCare Royalty Partners | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Monthly visitors increased 34% MoM.
- Jun 1, 2025
Monthly visitors grew 67% MoM, reaching 2,000.
For institutional investors. Book with your work email.
TheracosBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TheracosBio's valuation, stock price, and market status.
Is TheracosBio a public or private company?
TheracosBio is a private company.
What is the current stock price of TheracosBio?
TheracosBio is a private company, so its shares have no public market price. Caplight tracks TheracosBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TheracosBio worth (valuation)?
Valuation information for TheracosBio is not publicly available.
Can I buy TheracosBio stock?
TheracosBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TheracosBio's last funding round?
TheracosBio's most recent funding round was Debt on August 22, 2023.
Who are the main investors in TheracosBio?
Key investors in TheracosBio include HealthCare Royalty Partners.
Will TheracosBio IPO soon?
No public IPO plans have been announced for TheracosBio.
How can I track TheracosBio secondary market activity?
Caplight tracks bids, offers, and trades in TheracosBio's shares on secondary markets.